A Phase I Single Center Study of Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma
Phase of Trial: Phase I
Latest Information Update: 05 Dec 2016
At a glance
- Drugs Ranibizumab (Primary)
- Indications Eye neoplasms
- Focus Adverse reactions
- 01 Dec 2016 Status changed from active, no longer recruiting to completed.
- 14 Jun 2016 Planned End Date changed from 1 Dec 2016 to 1 Sep 2016.
- 09 Nov 2014 Planned End Date changed from 1 Dec 2015 to 1 Dec 2016, as reported by ClinicalTrials.gov.